Cellular membranes, mitochondria, and hyaluronan-rich tumor microenvironment

The target 'Cellular membranes, mitochondria, and hyaluronan-rich tumor microenvironment' refers to a multi-compartment therapeutic focus common in advanced oncology and nanomedicine. It encompasses the extracellular matrix (specifically the hyaluronan-rich stroma), the cellular boundary (membranes), and the intracellular energy centers (mitochondria). In many aggressive cancers, such as pancreatic ductal adenocarcinoma, an abundance of hyaluronan creates a dense, high-pressure microenvironment that acts as a physical barrier to conventional chemotherapy. Therapeutic strategies targeting this axis involve degrading the hyaluronan to lower interstitial pressure, facilitating the penetration of drugs through cellular membranes to reach the mitochondria. Once at the mitochondria, these agents can trigger apoptosis, effectively bypassing stromal resistance and directly inducing cell death in malignant cells.

Other names

HA-rich TMETumor stroma and intracellular compartmentsMitochondrial-targeted HA-nanoparticlesDesmoplastic tumor microenvironment

Enzymatic degradation of hyaluronan to reduce interstitial fluid pressure and enhance drug delivery to cellular membranes and mitochondria, followed by induction of mitochondrial-mediated apoptosis.